Literature DB >> 8751472

Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest.

R Tordjman1, E Macintyre, J F Emile, F Valensi, V Ribrag, M L Burtin, B Varet, N Brousse, O Hermine.   

Abstract

In the majority of clonal expansions of CD3+ large granular lymphocytes (LGL), referred to as T-LGL leukemia, patients have a chronic disease, often manifested by severe neutropenia, rheumatoid arthritis, and mild to moderate splenomegaly. The characteristic leukemic phenotype is CD3+, CD8+, CD16+, CD57+ and CD56-. Here we report an unusual case of T-LGL (CD3cyt+, CD3surface-, CD16+, CD56-) with clinicopathological features (acute presentation, large tumor mass, and systemic illness with highLGL counts at diagnosis) similar to those described for patients with CD3-natural killer (NK)-LGL leukemia. Two distinct stages of maturation arrest were observed: in the lymph node abnormal cells were CD4+, CD8+ whereas the majority of circulating leukemic cells expressed only CD8. TCR gamma (TCR gamma) gene configuration demonstrated that these originated from the same T cell clone, suggesting a maturation process between the two populations, or preferential passage of CD8 single positive cells into the blood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751472

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation.

Authors:  T Marchand; T Lamy; H Finel; W Arcese; S Choquet; J Finke; A Huynh; G Irrera; D Karakasis; J Konopacki; J Lambert; M Michieli; H C Schouten; W Schroyens; G Sucak; J Tischer; E Vandenberghe; P Dreger
Journal:  Leukemia       Date:  2015-09-22       Impact factor: 11.528

2.  CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia.

Authors:  Mary Theresa Sylvia; Sajini Elizabeth Jacob; Debdatta Basu; Deepak Amalnath; Tarun Kumar Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-13       Impact factor: 0.900

Review 3.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

4.  Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.

Authors:  Margaret Li Krackeler; Catherine Broome; Catherine Lai
Journal:  Stem Cell Investig       Date:  2020-12-29

Review 5.  Large granular lymphocyte leukemia.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 6.  Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.

Authors:  Yun Liu; Lei Fan; Huihui Zhao; Wei Xu; Jianyong Li
Journal:  Oncotarget       Date:  2017-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.